Showing results (51-60 of 165) with videos related to

Sort By:
Pageof 17
Journal of the American Pharmacists Association : Japha|October 9, 2025
The Minivisit Method: Adapting Opioid-Related Educational Outreach for Community PharmaciesMonica F Roberts, Patricia R Freeman, Laura K Stinson, et al.
Health & Justice|February 6, 2021
Adaptation of a standard extended-release naltrexone (XR-NTX) protocol for rural re-entering offenders with OUDMichele Staton, Hannah K Knudsen, Sharon L Walsh, et al.
Drug and Alcohol Dependence|May 29, 2016
Opioid withdrawal suppression efficacy of oral dronabinol in opioid dependent humansMichelle R Lofwall, Shanna Babalonis, Paul A Nuzzo, et al.
Clinical Pharmacology and Therapeutics|August 4, 2004
Ketoconazole, a cytochrome P450 3A4 inhibitor, markedly increases concentrations of levo-acetyl-alpha-methadol in opioid-naive individualsDavid E Moody, Sharon L Walsh, Douglas E Rollins, et al.
Drug and Alcohol Dependence|October 27, 2012
Abuse liability and reinforcing efficacy of oral tramadol in humansShanna Babalonis, Michelle R Lofwall, Paul A Nuzzo, et al.
Journal of Opioid Management|September 10, 2009
Prescription drug fatalities among women in rural Virginia: a study of medical examiner casesMartha J Wunsch, Kent Nakamoto, Paul A Nuzzo, et al.
Addiction (Abingdon, England)|March 15, 2011
The pharmacodynamic and pharmacokinetic profile of intranasal crushed buprenorphine and buprenorphine/naloxone tablets in opioid abusersLisa S Middleton, Paul A Nuzzo, Michelle R Lofwall, et al.
Drug and Alcohol Dependence|June 13, 2013
Efficacy of extended-release tramadol for treatment of prescription opioid withdrawal: a two-phase randomized controlled trialMichelle R Lofwall, Shanna Babalonis, Paul A Nuzzo, et al.
Psychopharmacology|June 26, 2010
Acute effects of intramuscular and sublingual buprenorphine and buprenorphine/naloxone in non-dependent opioid abusersAngela N Duke, Christopher J Correia, Sharon L Walsh, et al.
Psychopharmacology|July 29, 2010
Intravenous oxycodone, hydrocodone, and morphine in recreational opioid users: abuse potential and relative potenciesWilliam W Stoops, Kevin W Hatton, Michelle R Lofwall, et al.
Pageof 17